Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/31/2001EP1149898A2 Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
10/31/2001EP1149289A1 Whole cell selection utilizing azlactone-functional supports
10/31/2001EP1149170A1 Biologically active reverse transcriptases
10/31/2001EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001EP1149167A2 Viral vaccine
10/31/2001EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
10/31/2001EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
10/31/2001EP1149164A2 Neisseria meningitidis polypeptides
10/31/2001EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1148782A2 Plant resistance to insect pests mediated by viral proteins
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP0975783B1 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
10/31/2001EP0869806B1 A pharmaceutical composition comprising plant worms and muirapuama
10/31/2001EP0842279B1 Helper viruses for preparing recombinant viral vectors
10/31/2001EP0815141B1 Antibodies active against a fusion polypeptide comprising a histidine portion
10/31/2001EP0739229B1 Density gradient medium for separating cells
10/31/2001EP0699077B1 Hiv immunogenic complexes
10/31/2001EP0641183B1 Coated transplant and method for making same
10/31/2001EP0626998B1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna
10/31/2001EP0604551B1 New cell line which supports replication of baculoviruses
10/31/2001DE10019154A1 Zellbindende Nukleinsäuremoleküle (Aptamere) Cell-binding nucleic acid molecules (aptamers)
10/31/2001DE10014708A1 Verfahren zur Identifizierung und Anreicherung von zellspezifischen Zielstrukturen Method for the identification and enrichment of cell-specific target structures
10/31/2001CN1320162A Three-dimensional cell incubation media and method for incubatig by same
10/31/2001CN1320043A Mutant cholera holotoxin as an adjuvant
10/30/2001US6310275 Artificially synthesized gene for trypsin inhibitor
10/30/2001US6310272 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same
10/30/2001US6310270 Endothelial NOS knockout mice and methods of use
10/30/2001US6310197 Nucleotide sequences for use in treatment of alzheimer's disease
10/30/2001US6310195 Nucleic acid encoding a lectin-derived progenitor cell preservation factor
10/30/2001US6310194 Nucleotide sequences which code enzymatic polypetide; for use in controlling hydroxylation in transgenic plants
10/30/2001US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310045 Compositions and methods for cancer immunotherapy
10/30/2001US6309878 Glucose-inducible recombinant viral vector
10/30/2001US6309876 Expression vector for propagation of cells in nervous system; for treating nervous system damage; gene therapy
10/30/2001US6309866 6-phosphogluconate dehydrogenase
10/30/2001US6309862 Methionine containing animal cell culture medium and its use
10/30/2001US6309853 Nucleotide sequences coding polypeptide associated with contolling bdy weight; for use in diagnosis and treatment of eating disorders
10/30/2001US6309844 Immunoglobulin for use in the treatment and diagnosis of hyperlipidemia and arterial sclerosis
10/30/2001US6309841 Expression vector for the generation of stable genetically engineered polypeptides
10/30/2001US6309832 Screening for flea allergy dermatitis; immobilize flea allergen, incubate with immunoglobulin, remove unbound particles, screen sample for immunoglobulin complex formation
10/30/2001US6309830 Nucleotide sequence which encodes a synthetic transfer ribonucleic acid; for use as a tool in gene therapy
10/30/2001US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified.
10/30/2001US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host.
10/30/2001US6309645 A method of suppressing an immune response in a mammal.
10/30/2001US6309644 Parasitic nematode transglutaminase proteins and uses thereof
10/30/2001US6309640 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
10/30/2001US6309638 Netrins
10/30/2001US6309635 Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
10/30/2001US6309606 Device and method for the separation of human or animal cells of different densities from cellular dispersions which contain them
10/30/2001CA2170143C Cell death regulator
10/25/2001WO2001079851A1 NON-INVASIVE PRENATAL DIAGNOSIS USING CD45-ve FETAL CELLS
10/25/2001WO2001079845A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism
10/25/2001WO2001079538A2 Cell-binding nucleic acid molecules (aptamers)
10/25/2001WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001WO2001079518A2 Codon optimisation for expression in retrovirus packaging cells
10/25/2001WO2001079510A1 Materials and methods relating to immune responses to fusion proteins
10/25/2001WO2001079502A2 Vectors for gene therapy
10/25/2001WO2001079493A1 New lipid binding protein 2
10/25/2001WO2001079492A2 Lipid binding protein 3
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079465A2 Nucleic acids encoding polypeptides having haloperoxidase activity
10/25/2001WO2001079459A2 Polypeptides having haloperoxidase activity
10/25/2001WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001WO2001079453A1 Cell culture method, cell cluster obtained by said methods and use thereof
10/25/2001WO2001079452A2 Tolerance-inducing thy-marrow composite tissue construct and organ
10/25/2001WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001WO2001079445A2 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001WO2001079291A2 Secreted proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079283A1 Modulating cell survival by modulating huntingtin function
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001WO2001079273A2 Viruses comprising mutated ion channel protein
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079153A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
10/25/2001WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001WO2001078792A1 Method of inactivating pathogens
10/25/2001WO2001078776A1 Herpes virus complementing cell line
10/25/2001WO2001078761A2 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors
10/25/2001WO2001078757A2 Reversible immortalization
10/25/2001WO2001078756A2 Agent for postoperative use after the removal of bone tumours
10/25/2001WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001WO2001078753A2 Therapeutic uses for mesenchymal stromal cells
10/25/2001WO2001078752A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
10/25/2001WO2001078685A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing bmp-4
10/25/2001WO2001078611A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
1 ... 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 ... 1827